XML 14 R4.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
 3 Months Ended 6 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]        
Revenues $ 4,526,907 $ 4,824,289 $ 8,723,960 $ 9,145,544
Cost of Goods Sold 3,456,965 3,373,313 6,536,688 6,230,957
Gross Profit 1,069,942 1,450,976 2,187,272 2,914,587
Research and Development Expenses 317,747 221,728 718,406 434,486
Selling, General and Administrative Expenses 1,662,216 1,933,410 3,625,828 3,589,556
Total Operating Expenses 1,979,963 2,155,138 4,344,234 4,024,042
Operating Income (Loss) (910,021) (704,162) (2,156,962) (1,109,455)
Interest Expense (59,660) (54,640) (123,966) (113,762)
Net Income (Loss) $ (969,681) $ (758,802) $ (2,280,928) $ (1,223,217)
Income (Loss) Per Share:        
Income Loss Per Share, Basic $ (0.15) $ (0.13) $ (0.36) $ (0.20)
Income Loss Per Share, Fully diluted $ (0.15) $ (0.13) $ (0.36) $ (0.20)
Weighted average common shares outstanding, Basic 6,350,403 6,066,572 6,283,516 6,066,545
Weighted average common shares outstanding, Fully diluted 6,350,403 6,066,572 6,283,516 6,066,545